Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
MarketWatch·3h·Media
That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.
TickersGLP, CVSChannelsoil_gas, stocksCountriesusaCategoriesmarket-general
Open original source ↗Published
5/28/2026, 7:08:00 PM
Fetched
5/28/2026, 8:08:35 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
media · 60/100
Language
en